Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era
The advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee5e365aab4148eb825b97321157f28e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ee5e365aab4148eb825b97321157f28e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ee5e365aab4148eb825b97321157f28e2021-11-25T16:54:10ZRare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era10.3390/biom111117132218-273Xhttps://doaj.org/article/ee5e365aab4148eb825b97321157f28e2021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1713https://doaj.org/toc/2218-273XThe advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform detailed phenotypic characterizations of both physiological organs and experimental models. Recent years have seen the introduction of multiple techniques using NGS to profile transcription, DNA and chromatin modifications, protein binding, etc., that are now allowing us to profile cells in bulk or even at a single-cell level. Although rare and ultra-rare diseases only affect a few people, each of these diseases represent scholarly cases from which a great deal can be learned about the pathological and physiological function of genes, pathways, and mechanisms. Therefore, for rare diseases, state-of-the-art investigations using NGS have double valence: their genomic cause (new variants) and the characterize the underlining the mechanisms associated with them (discovery of gene function) can be found. In a non-exhaustive manner, this review will outline the main usage of NGS-based techniques for the diagnosis and characterization of neurodevelopmental disorders (NDDs), under whose umbrella many rare and ultra-rare diseases fall.Mattia ZaghiFederica BanfiEdoardo BelliniAlessandro SessaMDPI AGarticlenext-generation sequencing (NGS)neurodevelopmental disorders (NDDs)diagnosisexperimental modellinggene functionMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1713, p 1713 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
next-generation sequencing (NGS) neurodevelopmental disorders (NDDs) diagnosis experimental modelling gene function Microbiology QR1-502 |
spellingShingle |
next-generation sequencing (NGS) neurodevelopmental disorders (NDDs) diagnosis experimental modelling gene function Microbiology QR1-502 Mattia Zaghi Federica Banfi Edoardo Bellini Alessandro Sessa Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
description |
The advent of next-generation sequencing (NGS) is heavily changing both the diagnosis of human conditions and basic biological research. It is now possible to dig deep inside the genome of hundreds of thousands or even millions of people and find both common and rare genomic variants and to perform detailed phenotypic characterizations of both physiological organs and experimental models. Recent years have seen the introduction of multiple techniques using NGS to profile transcription, DNA and chromatin modifications, protein binding, etc., that are now allowing us to profile cells in bulk or even at a single-cell level. Although rare and ultra-rare diseases only affect a few people, each of these diseases represent scholarly cases from which a great deal can be learned about the pathological and physiological function of genes, pathways, and mechanisms. Therefore, for rare diseases, state-of-the-art investigations using NGS have double valence: their genomic cause (new variants) and the characterize the underlining the mechanisms associated with them (discovery of gene function) can be found. In a non-exhaustive manner, this review will outline the main usage of NGS-based techniques for the diagnosis and characterization of neurodevelopmental disorders (NDDs), under whose umbrella many rare and ultra-rare diseases fall. |
format |
article |
author |
Mattia Zaghi Federica Banfi Edoardo Bellini Alessandro Sessa |
author_facet |
Mattia Zaghi Federica Banfi Edoardo Bellini Alessandro Sessa |
author_sort |
Mattia Zaghi |
title |
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
title_short |
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
title_full |
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
title_fullStr |
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
title_full_unstemmed |
Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era |
title_sort |
rare does not mean worthless: how rare diseases have shaped neurodevelopment research in the ngs era |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/ee5e365aab4148eb825b97321157f28e |
work_keys_str_mv |
AT mattiazaghi raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera AT federicabanfi raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera AT edoardobellini raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera AT alessandrosessa raredoesnotmeanworthlesshowrarediseaseshaveshapedneurodevelopmentresearchinthengsera |
_version_ |
1718412871961935872 |